Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medicaid Spending On Accelerated Approvals ‘Outsized’ Relative To Use

Oct 20 2021

• By Cathy Kelly

Accelerated Approvals Burning Through Budgets? • Source: Alamy

Related Content

ODAC Report Card: Six Takeaways From Accelerated Approval Reviews Of Checkpoint Inhibitors

Apr 30 2021

MACPAC ‘Undeterred’ By Lukewarm Reception Of Accelerated Drug Approval Recommendation

Oct 20 2021

‘Dangling’ Accelerated Approval Reviews Expand At US FDA

Oct 08 2021

Revisiting Accelerated Approval: A Provocative Rebate Proposal

Apr 16 2021

Makena Follows Avastin’s Path With US FDA Hearing On Accelerated Approval Withdrawal

Aug 23 2021

Related Companies

Merck & Co., Inc.

Gilead Sciences, Inc.

Bristol Myers Squibb Company

Genentech, Inc.

Additional Topics

United States Reimbursement Medicaid Policy Approvals Pricing Debate BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window